We are delighted to be joined by Daniel Thomas, Managing Director, Chroma, who will be looking at both the clinical and cost-effectiveness of Chroma’s therapeutic modalities on Monday 24 June 2024 @ 10:30am.
The webinar will last an hour and will overview the research and best practices and provide video-based case studies. There will be time for Q&A at the end.
The Learning objectives for the webinar are:
- understanding the research behind the arts therapies, neurorehab/medical negligence/PI
- understanding why the arts therapies are clinically and cost effective
- understanding referral reasons and outcomes
- understanding the therapy process from case studies and results
Daniel Thomas’s Bio:
Daniel qualified as a music therapist in 2002. His clinical work focused on children and families, especially supporting attachment, bonding and resilience. Daniel has worked in prisons, mental health settings and in special and mainstream schools with children with a range of brain injuries and other conditions. He is a member of a number of umbrella organisations including the Academy of Neurologic Music Therapy the World Federation of Neurorehabilitation and sits on the Editorial Board of the NeuroRehab Times. He is the Managing Director of Chroma and values authenticity over perfection.
Book your spot today!
Please note if you are based overseas (this includes the Republic of Ireland) please make sure you book tickets to the webinar stated Overseas Business Customer to ensure you aren’t charged VAT. If you are based overseas and a non-business customer, or are unsure of what ticket to book, please email: kate@avma.org.uk.
Accredited by APIL Training
CPD: 1 Hour
-
June 24, 2024
10:30 am - 11:30 am
Venue: Online - Your computer
Description:
AvMA online events will stream from the AvMA webinar page.